3 bargain shares I’d buy in March

Can you afford to miss out on these deeply discounted shares?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With the stock market trading near an all-time high, it’s tough to find bargains in today’s market. However, not all stocks have recorded gains as high as others, and I think I’ve found three shares that seem deeply undervalued.

Strong order backlog

Shares in oil services company Petrofac (LSE: PFC) seem too cheap to ignore, with a forward P/E of 9.4 and a dividend yield of 6.2%.

Unlike many in the sector, Petrofac is attractively positioned due to its heavy exposure to the Middle East, where the relatively low costs of production in the region have shielded the company from savage cuts to capital spending in the oil & gas industry. What’s more, the company has adapted to lower energy prices by scaling back its Integrated Energy Services (IES) operations, which has helped to reduce its exposures to production risks.

As you might have guessed, Petrofac’s transformation isn’t without its difficulties. The company has made a number of writedowns and impairments, which resulted in it declaring a net loss of $349m in 2016. However, with cash flow from operations improving and steady revenue from new projects, Petrofac is delivering a strong operational performance across all its businesses and net debt is falling.

Additionally, Petrofac’s order backlog, which stands at $14.3bn (roughly double last year’s revenues), remains one of the most robust in the industry and gives it excellent revenue visibility over the next few years.

Overly cautious?

Housebuilder Redrow (LSE: RDW) may not be as well known as its larger rivals, but the company has been one of the most resilient in the sector since the Brexit vote last June. Shares in Redrow are currently trading near a post-recession high of 499p a share but they still seem undervalued.

Redrow is seeing business boom, thanks to a resilient residential property market in the South East and an increase in legal completions. In the six months to 31 December 2016, earnings per share (EPS) surged 35% to 31p a share. But City analysts expect earnings for the full-year to climb just 14% this year. This indicates that the market may be overly cautious on the stock, which opens up the possibility of earnings revisions over the next six months.

But even on those current estimates Redrow seems cheap, with shares trading at a forward P/E of just 7.5, which compares favourably to the sector average of 9.2.

First dividend payment?

Meanwhile, challenger bank Aldermore (LSE: ALD) seems poised to make its first dividend payment this year. The specialist mortgage and small business lender generated capital organically for the first time, and it has more capital than it needs to fund its growing loan book.

Looking ahead, Aldermore sees good tailwinds, with the bank expecting regulatory change to benefit smaller lenders and steady growth in buy-to-let lending. City analysts currently forecast its bottom line to have increased by 12% in 2016, with further growth of 11% expected for this year.

This gives it a forward P/E of just 8.2, which seems to offer excellent value for money for a stock which is soon to start making dividend payments. As such, I consider Aldermore a worthy buy at today’s price of 230p a share.

Jack Tang has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended Petrofac. The Motley Fool UK has recommended Redrow. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »